Covered recipient · General Payments record
BLEDAR HAXHIU
Allopathic & Osteopathic Physicians Family Medicine Addiction Medicine
General Payments · PY2019–2024
$1,960.95
- Reported across 51 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $625.29 | 10 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $248.12 | 2 |
| Braeburn Inc. | $211.81 | 3 |
| Acerta Pharma LLC | $86.94 | 1 |
| Neurocrine BioSciences, Inc. | $24.58 | 1 |
| Exact Sciences Corporation | $19.83 | 1 |
| Janssen Pharmaceuticals, Inc | $19.21 | 1 |
| Alkermes, Inc. | $14.80 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Alkermes, Inc. | $14.80 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120513771 | CMS |
| Amgen Inc. | $124.06 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111596424 | CMS |
| Amgen Inc. | $124.06 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111596426 | CMS |
| AstraZeneca Pharmaceuticals LP | $86.94 | 12/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104614738 | CMS |
| Braeburn Inc. | $16.08 | 01/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125599451 | CMS |
| Braeburn Inc. | $101.51 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125599455 | CMS |
| Braeburn Inc. | $94.22 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125599453 | CMS |
| Exact Sciences Corporation | $19.83 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114696442 | CMS |
| Janssen Pharmaceuticals, Inc | $19.21 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1077961356 | CMS |
| Neurocrine Biosciences, Inc. | $24.58 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150841258 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.